Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMA ADMA Biologics, Inc. daily Stock Chart
ADMA [NASD]
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-0.89 Insider Own0.70% Shs Outstand73.78M Perf Week25.35%
Market Cap322.00M Forward P/E- EPS next Y-0.25 Insider Trans- Shs Float62.78M Perf Month21.09%
Income-54.50M PEG- EPS next Q-0.16 Inst Own63.40% Short Float15.37% Perf Quarter11.25%
Sales36.00M P/S8.94 EPS this Y38.90% Inst Trans1.22% Short Ratio2.37 Perf Half Y-12.96%
Book/sh1.31 P/B2.72 EPS next Y62.70% ROA-35.20% Target Price- Perf Year11.60%
Cash/sh1.12 P/C3.18 EPS next 5Y- ROE-106.00% 52W Range1.45 - 5.48 Perf YTD-11.00%
Dividend- P/FCF- EPS past 5Y13.30% ROI- 52W High-47.01% Beta2.14
Dividend %- Quick Ratio8.10 Sales past 5Y37.80% Gross Margin-30.30% 52W Low100.43% ATR0.28
Employees313 Current Ratio11.90 Sales Q/Q191.40% Oper. Margin- RSI (14)45.39 Volatility14.97% 8.08%
OptionableYes Debt/Eq1.00 EPS Q/Q7.50% Profit Margin- Rel Volume2.94 Prev Close3.56
ShortableYes LT Debt/Eq1.00 EarningsAug 05 AMC Payout- Avg Volume4.06M Price2.91
Recom1.70 SMA20-6.16% SMA50-3.53% SMA200-16.04% Volume9,642,552 Change-18.36%
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Aug-05-20 07:25PM  
04:05PM  
07:35AM  
Aug-03-20 07:34AM  
Jul-29-20 07:00AM  
Jul-07-20 08:55AM  
Jul-06-20 07:00AM  
Jul-03-20 10:13AM  
Jun-23-20 12:49PM  
07:00AM  
Jun-09-20 03:21PM  
Jun-01-20 09:44AM  
May-27-20 07:00AM  
May-21-20 07:00AM  
May-07-20 10:30AM  
08:42AM  
07:35AM  
May-06-20 08:15PM  
04:05PM  
May-01-20 06:13AM  
Apr-29-20 07:00AM  
Apr-03-20 03:48AM  
Mar-17-20 06:12AM  
Mar-12-20 04:05PM  
02:30PM  
Mar-05-20 06:59AM  
Mar-03-20 07:00AM  
Feb-24-20 07:00AM  
Feb-13-20 05:07AM  
Feb-11-20 04:20PM  
Feb-07-20 07:32AM  
Feb-06-20 08:41PM  
04:06PM  
05:53AM  
Jan-09-20 07:00AM  
Jan-07-20 07:00AM  
Dec-23-19 05:36AM  
Dec-17-19 07:08AM  
Dec-14-19 08:04PM  
Nov-13-19 07:08AM  
Nov-08-19 05:33AM  
Nov-06-19 05:02PM  
Nov-04-19 07:08AM  
Oct-28-19 03:05PM  
Oct-22-19 07:48AM  
Oct-21-19 07:48AM  
Oct-17-19 07:29AM  
Oct-09-19 11:08AM  
Oct-07-19 07:08AM  
Oct-03-19 07:08AM  
Sep-23-19 07:08AM  
Sep-09-19 02:54PM  
Aug-22-19 07:48AM  
Aug-08-19 07:51AM  
07:08AM  
Jul-08-19 08:22AM  
Jun-27-19 09:30AM  
09:28AM  
Jun-18-19 04:35PM  
Jun-06-19 07:25AM  
May-30-19 06:14PM  
May-29-19 07:11AM  
May-24-19 10:30AM  
May-21-19 04:20PM  
09:15AM  
May-16-19 08:00AM  
May-15-19 04:35PM  
May-10-19 06:58AM  
May-08-19 07:03PM  
04:18PM  
Apr-17-19 07:08AM  
Apr-03-19 08:19AM  
Apr-02-19 06:58PM  
10:26AM  
09:00AM  
07:30AM  
Apr-01-19 08:09PM  
Mar-13-19 08:19PM  
05:05PM  
Feb-25-19 07:38AM  
Feb-12-19 12:30PM  
07:38AM  
Jan-07-19 07:08AM  
Dec-26-18 11:40AM  
Dec-23-18 07:25AM  
Dec-20-18 06:20PM  
06:08AM  
Dec-19-18 06:36PM  
06:10PM  
05:58PM  
09:18AM  
Dec-17-18 06:30AM  
Dec-16-18 02:18PM  
Nov-13-18 08:10AM  
Nov-08-18 05:27PM  
05:05PM  
Oct-30-18 10:00AM  
Oct-17-18 07:08AM  
Oct-11-18 08:48AM  
Oct-03-18 07:08AM  
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerMar 19Buy2.10500,0001,050,00016,584,802Mar 23 08:30 AM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 11Buy3.504,563,70015,972,95016,084,802Feb 11 08:02 AM
Guiheen Lawrence P.DirectorFeb 11Buy3.5020,00070,00070,000Feb 11 10:18 AM
Mond JamesCSO and CMOFeb 11Buy3.504,28514,99822,174Feb 11 10:16 AM
Grossman Jerrold BDirectorFeb 11Buy3.5022,85780,00022,857Feb 11 10:15 AM
Grossman Jerrold BDirectorFeb 11Buy3.5022,85780,000132,864Feb 11 10:15 AM
LENZ BRIANEVP, CFOFeb 11Buy3.507,14224,99732,142Feb 11 10:13 AM
Grossman Adam SPresident and CEOFeb 11Buy3.5057,143200,001878,444Feb 11 10:11 AM
Grossman Adam SPresident and CEOFeb 11Buy3.5028,57199,99966,098Feb 11 10:11 AM